Abstract
THE prevention of intrauterine death in erythroblastosis fetalis continues to elude solution though attacks on the problem have been made from a number of directions. Fifteen to 20 per cent of fetuses with erythroblastosis caused by Rh incompatibility die in utero between the gestational ages of seventeen and forty weeks — about half of these die before thirty weeks. Fortunately, stillbirth is rare in the large group of cases of erythroblastosis caused by A and B and other blood-group antigens. Anemia is assumed to be the basic cause of intrauterine death, and it probably should be considered an anemia secondary . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
